🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 5 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
13/04/2020 35,65 35,74 33,68 34,85 +2,89% 5,78% 1.559.100
09/04/2020 32,25 34,78 32,17 33,87 +7,49% 8,09% 1.436.200
08/04/2020 30,25 31,97 29,61 31,51 +7,21% 7,80% 1.121.100
07/04/2020 29,15 30,50 28,65 29,39 +1,55% 6,35% 1.469.300
06/04/2020 27,22 29,07 26,75 28,94 +10,80% 8,52% 1.262.500
03/04/2020 26,50 27,27 25,84 26,12 -2,94% 5,40% 598.800
02/04/2020 26,22 27,61 25,79 26,91 +1,47% 6,94% 912.400
01/04/2020 28,03 28,62 26,19 26,52 -7,82% 8,67% 1.005.300
31/03/2020 29,16 29,41 27,60 28,77 -0,69% 6,21% 1.311.000
30/03/2020 28,45 29,08 27,00 28,97 +3,02% 7,31% 1.134.800
27/03/2020 29,83 30,15 27,95 28,12 -8,07% 7,38% 1.302.000
26/03/2020 29,50 32,21 29,50 30,59 +4,69% 9,19% 1.641.300
25/03/2020 28,54 30,24 27,50 29,22 +2,06% 9,60% 1.975.800
24/03/2020 27,51 28,85 26,89 28,63 +11,92% 7,12% 1.724.800
23/03/2020 28,14 28,96 24,50 25,58 -7,95% 15,85% 2.043.800
20/03/2020 27,00 29,86 27,00 27,79 +6,88% 10,59% 3.559.000
19/03/2020 20,71 27,07 20,41 26,00 +26,46% 32,16% 2.884.800
18/03/2020 20,39 22,21 19,51 20,56 -6,42% 13,24% 2.364.200
17/03/2020 22,25 22,72 19,52 21,97 +0,97% 14,38% 2.824.000
16/03/2020 22,46 24,52 21,59 21,76 -17,33% 13,05% 2.601.000
13/03/2020 26,50 26,67 22,64 26,32 +5,24% 15,21% 2.682.900
12/03/2020 25,14 27,17 24,14 25,01 -12,43% 12,05% 2.774.100
11/03/2020 29,11 30,76 27,98 28,56 -4,45% 9,55% 1.954.500
10/03/2020 31,36 31,79 27,13 29,89 -0,37% 14,86% 2.064.900
09/03/2020 30,00 33,20 29,20 30,00 -10,18% 13,33% 2.176.300
06/03/2020 34,50 34,90 32,40 33,40 -6,15% 7,23% 1.760.700
05/03/2020 35,98 36,94 35,14 35,59 -3,63% 5,00% 1.169.100
04/03/2020 35,99 37,00 35,09 36,93 +5,06% 5,31% 1.198.300
03/03/2020 35,70 37,15 34,77 35,15 -0,99% 6,67% 1.443.500
02/03/2020 35,37 36,10 34,08 35,50 +0,40% 5,71% 1.387.900